Publications

1. Zeydan B, Johnson DR, Schwarz CG, Przybelski SA, Lesnick TG, Senjem ML, Kantarci OH, Min PH, Kemp BJ, Jack CR Jr, Kantarci K, Lowe VJ. Visual assessments of 11 C-Pittsburgh compound-B PET vs. 18 F-flutemetamol PET across the age spectrum. Nucl Med Commun. 2024 Dec 1; 45 (12):1047-1054 Epub 2024 Sept 13
   View PubMed
2. Zeydan B, Johnson DR, Schwarz CG, Lee J, Przybelski SA, Lesnick TG, Senjem ML, Kantarci OH, Min PH, Kemp BJ, Jack CR Jr, Kantarci K, Lowe VJ. Developing Topics. Alzheimers Dement. 2023 Dec; 19 Suppl 24:e082897
   View PubMed
3. Young JR, Mugu VK, Johnson GB, Ehman EC, Packard AT, Homb AC, Nathan MA, Thanarajasingam G, Kemp BJ. Bayesian penalized likelihood PET reconstruction impact on quantitative metrics in diffuse large B-cell lymphoma. Medicine (Baltimore). 2023 Feb 10; 102 (6):e32665
   View PubMed
4. Zeydan B, Schwarz CG, Przybelski SA, Lesnick TG, Kremers WK, Senjem ML, Kantarci OH, Min PH, Kemp BJ, Jack CR Jr, Kantarci K, Lowe VJ. Comparison of (11)C-Pittsburgh Compound B and (18)F-Flutemetamol White Matter Binding in PET. J Nucl Med. 2022 Aug; 63 (8):1239-1244 Epub 2021 Dec 16
   View PubMed
5. Thompson SM, Suman G, Torbenson MS, Chen ZE, Jondal DE, Patra A, Ehman EC, Andrews JC, Fleming CJ, Welch BT, Kurup AN, Roberts LR, Watt KD, Truty MJ, Cleary SP, Smoot RL, Heimbach JK, Tran NH, Mahipal A, Yin J, Zemla T, Wang C, Fogarty Z, Jacobson M, Kemp BJ, Venkatesh SK, Johnson GB, Woodrum DA, Goenka AH. PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and (68) Ga-PSMA-11 PET Using Cyclotron-Produced (68) Ga. Hepatol Commun. 2022 May; 6 (5):1172-1185 Epub 2021 Nov 15
   View PubMed
6. Catana C, Laforest R, An H, Boada F, Cao T, Faul D, Jakoby B, Jansen FP, Kemp BJ, Kinahan PE, Larson P, Levine MA, Maniawski P, Mawlawi O, McConathy JE, McMillan AB, Price JC, Rajagopal A, Sunderland J, Veit-Haibach P, Wangerin KA, Ying C, Hope TA. A Path to Qualification of PET/MRI Scanners for Multicenter Brain Imaging Studies: Evaluation of MRI-Based Attenuation Correction Methods Using a Patient Phantom. J Nucl Med. 2022 Apr; 63 (4):615-621 Epub 2021 July 22
   View PubMed
7. Panda A, Garg I, Truty MJ, Kline TL, Johnson MP, Ehman EC, Suman G, Anaam DA, Kemp BJ, Johnson GB, Halfdanarson TR, Venkatesh SK, Fidler JL, Goenka AH. Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival. AJR Am J Roentgenol. 2021 Sep; 217 (3):730-740 Epub 2020 Oct 21
   View PubMed
8. Laack NN, Pafundi D, Anderson SK, Kaufmann T, Lowe V, Hunt C, Vogen D, Yan E, Sarkaria J, Brown P, Kizilbash S, Uhm J, Ruff M, Zakhary M, Zhang Y, Seaberg M, Wan Chan Tseung HS, Kabat B, Kemp B, Brinkmann D. Initial Results of a Phase 2 Trial of (18)F-DOPA PET-Guided Dose-Escalated Radiation Therapy for Glioblastoma. Int J Radiat Oncol Biol Phys. 2021 Aug 1; 110 (5):1383-1395 Epub 2021 Mar 23
   View PubMed
9. Lopez BP, Jordan DW, Kemp BJ, Kinahan PE, Schmidtlein CR, Mawlawi OR. PET/CT acceptance testing and quality assurance: Executive summary of AAPM Task Group 126 Report. Med Phys. 2021 Feb; 48 (2):e31-e35 Epub 2021 Jan 05
   View PubMed
10. Qian J, Herman MG, Brinkmann DH, Laack NN, Kemp BJ, Hunt CH, Lowe V, Pafundi DH. Prediction of MGMT Status for Glioblastoma Patients Using Radiomics Feature Extraction From (18)F-DOPA-PET Imaging. Int J Radiat Oncol Biol Phys. 2020 Dec 1; 108 (5):1339-1346 Epub 2020 July 04
    View PubMed
11. Christopoulos C, Bois JP, Kemp BJ, Askew JW, Rodriguez-Porcel M, Gibbons RJ, Johnson GB, Chareonthatawee P. Comparison of Maximal Hyperemic Myocardial Blood Flow Response between regadenoson and adenosine Nuclear Medicine and Biomedical Imaging. 2020.
    
12. Sekine T, Buck A, Delso G, Kemp B, Ter Voert EEGW, Huellner M, Veit-Haibach P, Kaushik S, Wiesinger F, Warnock G, Alzheimer's Disease Neuroimaging Initiative. The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer's diseases- A simulation study combining multi-center data and ADNI-data. PLoS One. 2020; 15 (6):e0233886 Epub 2020 June 03
    View PubMed
13. Ando T, Kemp B, Warnock G, Sekine T, Kaushik S, Wiesinger F, Delso G. Zero Echo Time MRAC on FDG-PET/MR Maintains Diagnostic Accuracy for Alzheimer's Disease; A Simulation Study Combining ADNI-Data. Front Neurosci. 2020; 14:569706 Epub 2020 Nov 26
    View PubMed
14. Lehman VT, Diehn FE, Broski SM, Nathan MA, Kemp BJ, Larson NB, Shelerud RA, Brault JS, Halasy MP, Maus TP. Comparison of [(18)F] FDG-PET/MRI and Clinical Findings for Assessment of Suspected Lumbar Facet Joint Pain: A Prospective Study to Characterize Candidate Nonanatomic Imaging Biomarkers and Potential Impact on Management. AJNR Am J Neuroradiol. 2019 Oct; 40 (10):1779-1785 Epub 2019 Sept 26
    View PubMed
15. AbouEzzeddine OF, Kemp BJ, Borlaug BA, Mullan BP, Behfar A, Pislaru SV, Fudim M, Redfield MM, Chareonthaitawee P. Myocardial Energetics in Heart Failure With Preserved Ejection Fraction. Circ Heart Fail. 2019 Oct; 12 (10):e006240 Epub 2019 Oct 15
    View PubMed
16. Cao Y, Gathaiya N, Han Q, Kemp BJ, Jensen MD. Subcutaneous adipose tissue free fatty acid uptake measured using positron emission tomography and adipose biopsies in humans. Am J Physiol Endocrinol Metab. 2019 Aug 1; 317 (2):E194-E199 Epub 2019 Apr 23
    View PubMed
17. Battle MR, Pillay LC, Lowe VJ, Knopman D, Kemp B, Rowe CC, Dore V, Villemagne VL, Buckley CJ. Centiloid scaling for quantification of brain amyloid with [(18)F]flutemetamol using multiple processing methods. EJNMMI Res. 2018 Dec 5; 8 (1):107 Epub 2018 Dec 05
    View PubMed
18. Delso G, Kemp B, Kaushik S, Wiesinger F, Sekine T. Improving PET/MR brain quantitation with template-enhanced ZTE. Neuroimage. 2018 Nov 1; 181:403-413 Epub 2018 July 19
    View PubMed
19. Broski SM, Goenka AH, Kemp BJ, Johnson GB. Clinical PET/MRI: 2018 Update. AJR Am J Roentgenol. 2018 Aug; 211 (2):295-313 Epub 2018 June 27
    View PubMed
20. Han Q, Cao Y, Gathaiya N, Kemp BJ, Jensen MD. Free fatty acid flux measured using [1-(11)C]palmitate positron emission tomography and [U-(13)C]palmitate in humans. Am J Physiol Endocrinol Metab. 2018 May 1; 314 (5):E413-E417 Epub 2017 Oct 18
    View PubMed
21. Youland RS, Pafundi DH, Brinkmann DH, Lowe VJ, Morris JM, Kemp BJ, Hunt CH, Giannini C, Parney IF, Laack NN. Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas. J Neurooncol. 2018 May; 137 (3):583-591 Epub 2018 Jan 13
    View PubMed
22. Parvinian A, Martin-Macintosh EL, Goenka AH, Durski JM, Mullan BP, Kemp BJ, Johnson GB. (11)C-Choline PET/CT for Detection and Localization of Parathyroid Adenomas. AJR Am J Roentgenol. 2018 Feb; 210 (2):418-422 Epub 2017 Nov 15
    View PubMed
23. Jiang H, Schmit NR, Koenen AR, Bansal A, Pandey MK, Glynn RB, Kemp BJ, Delaney KL, Dispenzieri A, Bakkum-Gamez JN, Peng KW, Russell SJ, Gunderson TM, Lowe VJ, DeGrado TR. Safety, pharmacokinetics, metabolism and radiation dosimetry of (18)F-tetrafluoroborate ((18)F-TFB) in healthy human subjects. EJNMMI Res. 2017 Oct 27; 7 (1):90
    View PubMed
24. Leung N, Ramirez-Alvarado M, Nasr SH, Kemp BJ, Johnson GB. Detection of ALECT2 amyloidosis by positron emission tomography-computed tomography imaging with florbetapir. Br J Haematol. 2017 Apr; 177 (1):12 Epub 2017 Jan 20
    View PubMed
25. Schwarz CG, Senjem ML, Gunter JL, Tosakulwong N, Weigand SD, Kemp BJ, Spychalla AJ, Vemuri P, Petersen RC, Lowe VJ, Jack CR Jr. Optimizing PiB-PET SUVR change-over-time measurement by a large-scale analysis of longitudinal reliability, plausibility, separability, and correlation with MMSE. Neuroimage. 2017 Jan 1; 144 (Pt A):113-127 Epub 2016 Aug 27
    View PubMed
26. Lowe VJ, Lundt E, Knopman D, Senjem ML, Gunter JL, Schwarz CG, Kemp BJ, Jack CR Jr, Petersen RC. Comparison of [(18)F]Flutemetamol and [(11)C]Pittsburgh Compound-B in cognitively normal young, cognitively normal elderly, and Alzheimer's disease dementia individuals. Neuroimage Clin. 2017; 16:295-302 Epub 2017 Aug 14
    View PubMed
27. Schwarz CG, Senjem ML, Gunter JL, Kemp BJ, Spychalla AJ, Vemuri P, Lowe VJ, Jack CR Jr, Senjem ML, Gunter JL, Tosakulwong N, Weigand SD, Petersen RC. Optimizing PiB-PET SUVR change-over-time measurement by a large-scale analysis of longitudinal reliability, plausibility, separability, and correlation with MMSE NeuroImage. 2017; 144:113-27.
    
28. Vemuri P, Lowe VJ, Knopman DS, Senjem ML, Kemp BJ, Schwarz CG, Przybelski SA, Machulda MM, Petersen RC, Jack CR Jr. Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition. Alzheimers Dement (Amst). 2017; 6:21-30 Epub 2016 Dec 21
    View PubMed
29. Wollenweber SD, Kemp BJ. Technical Note: Rod phantom analysis for comparison of PET detector sampling and reconstruction methods. Med Phys. 2016 Nov; 43: (11)6175.
    View PubMed
30. Camp JJ, Hanson DP, Lowe VJ, Kemp BJ, Senjem ML, Murray ME, Dickson DW, Parisi JE, Petersen RC, Robb RA, Holmes DR III. Quantitative characterization of brain beta-amyloid in 718 normal subjects using a joint PiB/FDG PET image histogram Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2016; 9785:97852V.
    
31. DeGrado TR, Kemp BJ, Pandey MK, Jiang H, Gunderson TM, Linscheid LR, Woodwick AR, McConnell DM, Fletcher JG, Johnson GB, Petersen RC, Knopman DS, Lowe VJ. First PET Imaging Studies With 63Zn-Zinc Citrate in Healthy Human Participants and Patients With Alzheimer Disease. Mol Imaging. 2016; 15 Epub 2016 Dec 09
    View PubMed
32. Aggarwal NR, Drozdova A, Askew JW 3rd, Kemp BJ, Chareonthaitawee P. Feasibility and diagnostic accuracy of exercise treadmill nitrogen-13 ammonia PET myocardial perfusion imaging of obese patients. J Nucl Cardiol. 2015 Dec; 22 (6):1273-80 Epub 2015 Mar 17
    View PubMed
33. Kemp BJ, Peterson WT, Uribe J, Williams JJ, Lowe VJ, Stearns CW. Performance measurements of a PET/CT system with prototype SiPM detectors 2015 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2015. 2015; 7582091.
    
34. Johnson GB, Peller PJ, Kemp BJ, Ryu JH. Future of thoracic PET scanning. Chest. 2015 Jan; 147: (1)25-30.
    View PubMed
35. Wollenweber SD, Kemp BJ. Phantom analysis for characterization and comparison of PET detector sampling and reconstruction settings 2015 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2015. 2015; 7582039.
    
36. Hames KC, Vella A, Kemp BJ, Jensen MD. Free fatty acid uptake in humans with CD36 deficiency. Diabetes. 2014 Nov; 63 (11):3606-14 Epub 2014 June 10
    View PubMed
37. Camp JJ, Hanson DP, Holmes DR, Kemp BJ, Senjem ML, Murray ME, Dickson DW, Parisi JE, Petersen RC, Lowe VJ, Robb RA. Quantitative characterization of brain beta-amyloid using a joint PiB/FDG PET image histogram. Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2014; 9035:90352A.
    
38. Marmor YN, Kemp BJ, Huschka TR, Ruter RL, McConnell DM, Rohleder TR. Improving patient access in nuclear medicine: a case study of PET scanner scheduling. Qual Manag Health Care. 2013 Oct-Dec; 22(4):293-305.
    View PubMed
39. Pafundi DH, Laack NN, Youland RS, Parney IF, Lowe VJ, Giannini C, Kemp BJ, Grams MP, Morris JM, Hoover JM, Hu LS, Sarkaria JN, Brinkmann DH. Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study. Neuro Oncol. 2013 Aug; 15 (8):1058-67 Epub 2013 Mar 03
    View PubMed
40. Tabibian JH, Macura SI, O'Hara SP, Fidler JL, Glockner JF, Takahashi N, Lowe VJ, Kemp BJ, Mishra PK, Tietz PS, Splinter PL, Trussoni CE, LaRusso NF. Micro-computed tomography and nuclear magnetic resonance imaging for noninvasive, live-mouse cholangiography. Lab Invest. 2013 Jun; 93 (6):733-43 Epub 2013 Apr 15
    View PubMed
41. Cha YM, Chareonthaitawee P, Dong YX, Kemp BJ, Oh JK, Miyazaki C, Hayes DL, Rea RF, Asirvatham SJ, Webster TL, Dalzell CM, Hodge DO, Herges RM, Yong YZ, Zhang Y, Chen PS. Cardiac sympathetic reserve and response to cardiac resynchronization therapy. Circ Heart Fail. 2011 May; 4(3):339-44. Epub 2011 Mar 18.
    View PubMed
42. Klausen TL, Andersen F, Kemp B. Hardware and software approaches to multi-modality imaging. Current Medical Imaging Reviews. 2011; 7(3):169-74.
    
43. Kantarci K, Senjem ML, Lowe VJ, Wiste HJ, Weigand SD, Kemp BJ, Frank AR, Shiung MM, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr. Effects of age on the glucose metabolic changes in mild cognitive impairment. AJNR Am J Neuroradiol. 2010 Aug; 31 (7):1247-53 Epub 2010 Mar 18
    View PubMed
44. Lowe VJ, Kemp BJ, Jack CR Jr, Senjem M, Weigand S, Shiung M, Smith G, Knopman D, Boeve B, Mullan B, Petersen RC. Comparison of 18F-FDG and PiB PET in cognitive impairment. J Nucl Med. 2009 Jun; 50 (6):878-86 Epub 2009 May 14
    View PubMed
45. Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC, Alzheimer's Disease Neuroimaging Initiative. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain. 2009 May; 132 (Pt 5):1355-65 Epub 2009 Mar 31
    View PubMed
46. Kemp BJ, Hruska CB, McFarland AR, Lenox MW, Lowe VJ. NEMA NU 2-2007 performance measurements of the Siemens Inveon preclinical small animal PET system. Phys Med Biol. 2009 Apr 21; 54 (8):2359-76 Epub 2009 Mar 25
    View PubMed
47. Camp J, Simpson K, Bardsley MR, Popko LN, Young DL, Kemp BJ, Lowe V, Ordog T, Robb R. 3D registration of micro-PET-CT for measurable correlates of dyspeptic symptoms in mice. Proc SPIE Int Soc Opt Eng. 2009 Feb 27; 7262:72620Z
    View PubMed
48. Carlson SK, Classic KL, Hadac EM, Dingli D, Bender CE, Kemp BJ, Russell SJ. Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene. AJR Am J Roentgenol. 2009 Jan; 192 (1):279-87
    View PubMed
49. Cha YM, Oh J, Miyazaki C, Hayes DL, Rea RF, Shen WK, Asirvatham SJ, Kemp BJ, Hodge DO, Chen PS, Chareonthaitawee P. Cardiac resynchronization therapy upregulates cardiac autonomic control. J Cardiovasc Electrophysiol. 2008 Oct; 19 (10):1045-52 Epub 2008 May 09
    View PubMed
50. Atkinson DM, Clarke MJ, Mladek AC, Carlson BL, Trump DP, Jacobson MS, Kemp BJ, Lowe VJ, Sarkaria JN. Using fluorodeoxythymidine to monitor anti-EGFR inhibitor therapy in squamous cell carcinoma xenografts. Head Neck. 2008 Jun; 30(6):790-9.
    View PubMed
51. Jack CR Jr, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, Knopman DS, Boeve BF, Klunk WE, Mathis CA, Petersen RC. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain. 2008 Mar; 131 (Pt 3):665-80 Epub 2008 Feb 07
    View PubMed
52. Christenson SD, Chareonthaitawee P, Burnes JE, Hill MR, Kemp BJ, Khandheria BK, Hayes DL, Gibbons RJ. Effects of simultaneous and optimized sequential cardiac resynchronization therapy on myocardial oxidative metabolism and efficiency. J Cardiovasc Electrophysiol. 2008 Feb; 19(2):125-32. Epub 2007 Oct 24.
    View PubMed
53. Doyle B, Kemp BJ, Chareonthaitawee P, Reed C, Schmeckpeper J, Sorajja P, Russell S, Araoz P, Riederer SJ, Caplice NM. Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction. J Nucl Med. 2007 Oct; 48: (10)1708-14.
    View PubMed
54. Kemp BJ, Kim C, Williams JJ, Ganin A, Lowe VJ, National Electrical Manufacturers Association (NEMA). NEMA NU 2-2001 performance measurements of an LYSO-based PET/CT system in 2D and 3D acquisition modes. J Nucl Med. 2006 Dec; 47(12):1960-7.
    View PubMed
55. Carlson SK, Classic KL, Hadac EM, Bender CE, Kemp BJ, Lowe VJ, Hoskin TL, Russell SJ. In vivo quantitation of intratumoral radioisotope uptake using micro-single photon emission computed tomography/computed tomography. Mol Imaging Biol. 2006 Nov-Dec; 8 (6):324-32
    View PubMed
56. O'Connor MK, Kemp BJ. Single-photon emission computed tomography/computed tomography: basic instrumentation and innovations. Semin Nucl Med. 2006 Oct; 36(4):258-66.
    View PubMed
57. Chareonthaitawee P, Christenson SD, Anderson JL, Kemp BJ, Hodge DO, Ritman EL, Gibbons RJ. Reproducibility of measurements of regional myocardial blood flow in a model of coronary artery disease: Comparison of H215O and 13NH3 PET techniques. J Nucl Med. 2006 Jul; 47(7):1193-201.
    View PubMed
58. Dingli D, Kemp BJ, O'Connor MK, Morris JC, Russell SJ, Lowe VJ. Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor. Mol Imaging Biol. 2006 Jan-Feb; 8 (1):16-23
    View PubMed
59. Badawi RD, Domigan P, Johnson O, Kemp B, Kudrolli H, Rempel T, Rohatgi R, Romanov LV, Surti S, Worstell WA, Zimmerman RE. Count-rate dependent event mispositioning and NEC in PET. IEEE Trans Nucl Sci. 2004 Feb; 51(1 Part 1):41-5.
    
60. O'connor MK, Kemp B, Anstett F, Christian P, Ficaro EP, Frey E, Jacobs M, Kritzman JN, Pooley RA, Wilk M. A multicenter evaluation of commercial attenuation compensation techniques in cardiac SPECT using phantom models. J Nucl Cardiol. 2002 Jul-Aug; 9 (4):361-76
    View PubMed
61. O'Connor MK, Kemp B, Anstett F, Christian P, Ficaro EP, Frey E, Jacobs M, Kritzman JN, Pooley RA, Wilk M. A multi-center evaluation of commercial attenuation compensation techniques in cardiac SPECT using phantom models. J Nucl Card. 2002; 9:361-76.
    
62. Stodilka RZ, Kemp BJ, Prato FS, Kertesz A, Kuhl D, Nicholson RL. Scatter and attenuation for brain SPECT using attenuation distributions inferred from a head atlas. J Nucl Med. 2000; 41:1569-78.
    View PubMed
63. Stodilka RZ, Kemp BJ, Msaki P, Prato FS, Nicholson RL. The relative contributions of scatter and attenuation corrections toward improved brain SPECT quantification. Physics in Medicine & Biology. 1998 Oct; 43(10):2991-3008.
    View PubMed
64. Stodilka RZ, Kemp BJ, Prato FS, Nicholson RL. Importance of bone attenuation in brain SPECT quantification. J Nucl Med. 1998 Jan; 39(1):190-7.
    View PubMed
65. Taylor A, Manatunga A, Morton K, Reese L, Prato FS, Greenberg E, Folks R, Kemp BJ, Jones ME, Corrigan PE, Galt J, Eshima L. Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance. Radiology. 1997 Jul; 204(1):47-54.
    View PubMed
66. Kemp BJ, Prato FS, Nicholson RL. The geometric modulation transfer function of a transmission imaging system that uses a SPECT scintillation camera and parallel hole collimation. Med Phys. 1995 Jun; 22(6):733-41.
    View PubMed
67. Kemp BJ, Prato FS, Nicholson RL, Reese L. Transmission computed tomography imaging of the head with a SPECT system and a collimated line source. J Nucl Med. 1995 Feb; 36(2):328-35.
    View PubMed
68. Karbe H, Kertesz A, Davis J, Kemp BJ, Prato FS, Nicholson RL. Quantification of functional deficit in Alzheimer's disease using a computer-assisted mapping program for 99mTc-HMPAO SPECT. Neuroradiology. 1994; 36(1):1-6.
    View PubMed
69. Kemp BJ, Prato FS, Dean GW, Nicholson RL, Reese L. Correction for attenuation in technetium-99m-HMPAO SPECT brain imaging. J Nucl Med. 1992 Oct; 33(10):1875-80.
    View PubMed
70. Kemp BJ, Prato FS, Reese L. Transmission CT of the head using a SPECT system equipped with a collimated line source and a fan beam collimator. Society of Nuclear Medicine, Eastern Great Lakes Chapter, 13th annual meeting. 1992 Apr.